The latest HCT is certainly NOT OVERSTATED but certainly...

The latest HCT is certainly NOT OVERSTATED but certainly outlines a few key points that could see the company have revenues coming in from China in the future IMO

It would seem HCT is targeting the HOSPITAL/MEDICAL market for PRODUCTS based on their business partner applying for medical use standards.

NATSHIELD
NASAL BALM????
M3 Fogging Machine

Is this the precursor to a major re-rating of HCT???
Is this the precursor for major sales in to China???
Is the Ovine Collagen the next approval???


I would rather be a holder of shares than siting on the side lines if the company goes in to a trading halt and announces something BIG lets all remember Zoono!!!



The approval, which was granted by the China National Intellectual Property
Administration (CNIPA), is for Trademark Class 5 – a category that relates mainly to
pharmaceuticals and other preparations for medical or veterinary purposes.

The trademark is valid for 10 years and it provides brand name protection as Holista
prepares to launch its NatshieldTM aerosol disinfectant and M3 System for industrial
applications in the Chinese market.

No further approvals are needed for commercialisation purposes.


Further, Holista’s Chinese business partner Guangzhou Sinbio Cosmetic Co Ltd will
soon commence the process of applying for medical use standards for products to
be sold into hospital.